Key insights
- A director at Ichor Holdings (ICHR) sold a significant amount of stock, raising concerns despite strong recent earnings and a raised price target from Needham. The sale, occurring near the stock's 52-week high, coupled with an InvestingPro analysis suggesting the stock is overvalued, points to potential downside risk for ICHR shares.
Marc Haugen, a director at Ichor Holdings, Ltd. (NASDAQ:ICHR), sold shares of the company’s ordinary stock on May 13, 2026. The transaction involved 5,337 shares, which were disposed of at a price of $75.63 per share, totaling approximately $403,637. The sale comes as the stock trades near its 52-week high of $78, following a remarkable 285% return over the past year. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value.
Following this direct sale, Mr. Haugen’s direct ownership in Ichor Holdings stands at 10,825 ordinary shares. For deeper insights into ICHR’s valuation and insider activity, investors can access the comprehensive Pro Research Report, available for this and 1,400+ other US equities.
In other recent news, Ichor Holdings reported impressive financial results for the first quarter of 2026. The company achieved revenue of $256.1 million, surpassing the forecasted $235.59 million and marking a 15% increase from the previous quarter. Additionally, Ichor Holdings posted an earnings per share (EPS) of $0.15, significantly beating the expected $0.06. This performance was accompanied by non-GAAP gross margins that were near the high end of the guided range. Following these results, Needham raised its price target for Ichor Holdings from $48 to $72 while maintaining a Buy rating. These developments underscore the company’s strong financial performance and positive outlook from analysts.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for ICHR plus thousands of other stocks and find your next hidden gem with massive upside.